131 related articles for article (PubMed ID: 19886718)
1. Carcinoma of the breast with medullary-like features: diagnostic challenges and relationship with BRCA1 and EZH2 functions.
Kleer CG
Arch Pathol Lab Med; 2009 Nov; 133(11):1822-5. PubMed ID: 19886718
[TBL] [Abstract][Full Text] [Related]
2. Medullary carcinoma of breast with a novel germline mutation 1123T >G in exon 11 of BRCA1.
Moattar T; Kausar T; Aban M; Khan S; Pervez S
J Coll Physicians Surg Pak; 2006 Sep; 16(9):606-7. PubMed ID: 16945238
[TBL] [Abstract][Full Text] [Related]
3. [Recent advances on EZH2 in malignant tumors].
Li J; Fan QH
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):856-8. PubMed ID: 20193471
[No Abstract] [Full Text] [Related]
4. Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1.
Gonzalez ME; Li X; Toy K; DuPrie M; Ventura AC; Banerjee M; Ljungman M; Merajver SD; Kleer CG
Oncogene; 2009 Feb; 28(6):843-53. PubMed ID: 19079346
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
De Brot M; Rocha RM; Soares FA; Gobbi H
Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
[TBL] [Abstract][Full Text] [Related]
6. BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.
Puppe J; Drost R; Liu X; Joosse SA; Evers B; Cornelissen-Steijger P; Nederlof P; Yu Q; Jonkers J; van Lohuizen M; Pietersen AM
Breast Cancer Res; 2009; 11(4):R63. PubMed ID: 19709408
[TBL] [Abstract][Full Text] [Related]
7. Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers.
Lee ST; Li Z; Wu Z; Aau M; Guan P; Karuturi RK; Liou YC; Yu Q
Mol Cell; 2011 Sep; 43(5):798-810. PubMed ID: 21884980
[TBL] [Abstract][Full Text] [Related]
8. The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer.
Zeidler M; Kleer CG
J Mol Histol; 2006 Sep; 37(5-7):219-23. PubMed ID: 16855786
[TBL] [Abstract][Full Text] [Related]
9. Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Warmoes M; Lam SW; van der Groep P; Jaspers JE; Smolders YH; de Boer L; Pham TV; Piersma SR; Rottenberg S; Boven E; Jonkers J; van Diest PJ; Jimenez CR
Oncotarget; 2016 Sep; 7(39):63537-63548. PubMed ID: 27566577
[TBL] [Abstract][Full Text] [Related]
10. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
[TBL] [Abstract][Full Text] [Related]
11. Typical medullary breast carcinomas have a basal/myoepithelial phenotype.
Jacquemier J; Padovani L; Rabayrol L; Lakhani SR; Penault-Llorca F; Denoux Y; Fiche M; Figueiro P; Maisongrosse V; Ledoussal V; Martinez Penuela J; Udvarhely N; El Makdissi G; Ginestier C; Geneix J; Charafe-Jauffret E; Xerri L; Eisinger F; Birnbaum D; Sobol H; ;
J Pathol; 2005 Nov; 207(3):260-8. PubMed ID: 16167361
[TBL] [Abstract][Full Text] [Related]
12. Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer.
Iau PT; Marafie M; Ali A; Sng JH; Macmillan RD; Pinder S; Denley HE; Ellis IO; Wenzyck P; Scott N; Cross G; Blamey RW
Breast Cancer Res Treat; 2004 May; 85(1):81-8. PubMed ID: 15039599
[TBL] [Abstract][Full Text] [Related]
13. The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors.
Panousis D; Patsouris E; Lagoudianakis E; Pappas A; Kyriakidou V; Voulgaris Z; Xepapadakis G; Manouras A; Athanassiadou AM; Athanassiadou P
Eur J Gynaecol Oncol; 2011; 32(2):156-9. PubMed ID: 21614903
[TBL] [Abstract][Full Text] [Related]
14. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
Rodríguez-Pinilla SM; Rodríguez-Gil Y; Moreno-Bueno G; Sarrió D; Martín-Guijarro Mdel C; Hernandez L; Palacios J
Am J Surg Pathol; 2007 Apr; 31(4):501-8. PubMed ID: 17414096
[TBL] [Abstract][Full Text] [Related]
15. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
Collins LC; Martyniak A; Kandel MJ; Stadler ZK; Masciari S; Miron A; Richardson AL; Schnitt SJ; Garber JE
Am J Surg Pathol; 2009 Jul; 33(7):1093-7. PubMed ID: 19390427
[TBL] [Abstract][Full Text] [Related]
16. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
17. Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder.
Hinz S; Kempkensteffen C; Christoph F; Hoffmann M; Krause H; Schrader M; Schostak M; Miller K; Weikert S
J Cancer Res Clin Oncol; 2008 Mar; 134(3):331-6. PubMed ID: 17694325
[TBL] [Abstract][Full Text] [Related]
18. Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
Cao Q; Yu J; Dhanasekaran SM; Kim JH; Mani RS; Tomlins SA; Mehra R; Laxman B; Cao X; Yu J; Kleer CG; Varambally S; Chinnaiyan AM
Oncogene; 2008 Dec; 27(58):7274-84. PubMed ID: 18806826
[TBL] [Abstract][Full Text] [Related]
19. Medullary carcinoma, provocative now as then.
Eichhorn JH
Semin Diagn Pathol; 2004 Feb; 21(1):65-73. PubMed ID: 15074561
[TBL] [Abstract][Full Text] [Related]
20. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
